logo
Plus   Neg
Share
Email

Did You Pay RAPT Attention?

Shares of RAPT Therapeutics Inc. (RAPT) touched a new high of $49.20 in intraday trading on Monday, before closing at $48.86, up 16.31%.

RAPT is a clinical-stage immunology-based biopharmaceutical company developing therapies for cancer and inflammatory diseases.

We alerted our readers to RAPT on January 15, 2020, after the market close.

Related Reading

RAPT Therapeutics Gains 29% In 5 Days, FLX475 Phase 2 Data Due In Q2

RAPT has thus far hit a low of $11.85 and a high of $49.20.

For comments and feedback contact: editorial@rttnews.com

Business News

RELATED NEWS
Follow RTT
>